HealthEquity: Robust Growth, But No Margin Of Safety

Group 1 - HealthEquity (NASDAQ: HQY) has experienced a decline of almost 15.00% over the past month, indicating a potential buying opportunity for investors [1] - The company is viewed as heavily undervalued, suggesting significant upside potential for long-term growth dividend investors [1] - The focus is on long-term compounding through investments in undervalued companies, aligning with the strategy of value dividend investing [1]